Form 4: SeaStar Medical Holding Corp: Chief Medical Officer Increases Stake

Kevin Chung, Chief Medical Officer of SeaStar Medical Holding Corp, recently purchased 4,500 shares of common stock at $1.25 per share.

Summary

• On May 20, 2025, Kevin Chung, the Chief Medical Officer of SeaStar Medical Holding Corp, purchased 4,500 shares of the company's common stock.
• The purchase price was $1.25 per share.
• Following the transaction, Chung directly owns 18,185 shares of SeaStar Medical Holding Corp.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The purchase of shares by a key executive is generally a good sign, but the scale of the purchase is not large enough to be overwhelmingly positive.

Positives

• The Chief Medical Officer's purchase of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that a company insider believes the stock is undervalued or that the company's prospects are strong. However, it's just one factor to consider when evaluating a stock.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

SeaStar Medical Holding Corp, insider trading, Form 4, ICU, Kevin Chung, Chief Medical Officer, stock purchase, beneficial ownership